Taiwan Biomaterial Co., Ltd.(TW:6649)
NT$35.65-0.25 (-0.70%)
TW:6649
Taiwan Biomaterial Co., Ltd. financials statements
NT$35.65
At close:-0.25 (-0.70%)
Taiwan Biomaterial Co., Ltd. (6649) Financial Statements
Taiwan Biomaterial Co., Ltd. Financial Overview
Taiwan Biomaterial Co., Ltd.'s market cap is currently NT$1.51B. The company's EPS TTM is NT$0.78; its P/E ratio is 45.87; and it has a dividend yield of 2.79%. Taiwan Biomaterial Co., Ltd. has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | NT$ 220.40M | NT$ 96.57M | NT$ 72.84M | NT$ 127.31M | NT$ 41.67M |
| Gross Profit | NT$ 123.10M | NT$ 57.31M | NT$ 47.12M | NT$ 76.09M | NT$ 21.09M |
| Operating Income | NT$ 60.83M | NT$ -11.23M | NT$ -14.22M | NT$ 25.46M | NT$ -56.72M |
| EBITDA | NT$ 76.30M | NT$ 15.99M | NT$ 9.71M | NT$ 51.63M | NT$ -35.35M |
| Net Income | NT$ 58.93M | NT$ -1.73M | NT$ -10.13M | NT$ 33.76M | NT$ -47.44M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | NT$ 355.90M | NT$ 312.84M | NT$ 304.18M | NT$ 332.65M | NT$ 152.65M |
| Total Assets | NT$ 789.95M | NT$ 704.56M | NT$ 716.28M | NT$ 735.31M | NT$ 553.79M |
| Total Debt | NT$ 52.59M | NT$ 56.99M | NT$ 60.70M | NT$ 68.51M | NT$ 79.64M |
| Net Debt | NT$ -205.81M | NT$ -148.35M | NT$ -110.98M | NT$ -114.64M | NT$ -12.01M |
| Total Liabilities | NT$ 104.86M | NT$ 78.39M | NT$ 88.38M | NT$ 88.89M | NT$ 130.89M |
| Stockholders' Equity | NT$ 685.09M | NT$ 626.16M | NT$ 627.89M | NT$ 646.42M | NT$ 422.89M |
| Cash Flow | |||||
| Free Cash Flow | NT$ 47.33M | NT$ 13.78M | NT$ -13.38M | NT$ -2.45M | NT$ -61.71M |
| Operating Cash Flow | NT$ 48.77M | NT$ 18.43M | NT$ -10.16M | NT$ 35.02M | NT$ -32.01M |
| Investing Cash Flow | NT$ 6.95M | NT$ 20.53M | NT$ 13.98M | NT$ -120.55M | NT$ 48.34M |
| Financing Cash Flow | NT$ -2.66M | NT$ -5.29M | NT$ -15.29M | NT$ 177.03M | NT$ 4.51M |
Currency in TWD
